www.fdanews.com/articles/159819-phase-iii-studies-show-stelara-inhibits-structural-damage-in-psoriatic-arthritis-patients

Phase III Studies Show Stelara Inhibits Structural Damage in Psoriatic Arthritis Patients

October 30, 2013

Results from two Phase III trials of Janssen’s Stelara show the drug more effectively prevents structural damage from psoriatic arthritis when compared with a placebo.
News Medical